Alyse D. Portnoff
Novavax (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Monoclonal and Polyclonal Antibodies Research, Animal Virus Infections Studies, Viral gastroenteritis research and epidemiology
Most-Cited Works
- → SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice(2021)522 cited
- → Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate(2020)377 cited
- → A Comparison of Postoperative Complications in Open versus Robotic Cystectomy(2009)295 cited
- → NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge(2020)240 cited
- → Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination(2021)145 cited
- → Critical analysis of complications after robotic‐assisted radical cystectomy with identification of preoperative and operative risk factors(2009)102 cited
- → Ubiquibodies, Synthetic E3 Ubiquitin Ligases Endowed with Unnatural Substrate Specificity for Targeted Protein Silencing(2014)84 cited
- → SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 elicits immunogenicity in baboons and protection in mice(2020)64 cited
- → Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA(2020)44 cited